Literature DB >> 22002334

Drug-related hypertension and resistance to antihypertensive treatment: a call for action.

Gian P Rossi1, Teresa M Seccia, Carmela Maniero, Achille C Pessina.   

Abstract

Several drugs can cause hypertension and/or blunt the effect of antihypertensive treatment. They can exacerbate a previously well controlled hypertension and/or render it resistant to therapy. Accordingly, drugs represent a common cause of resistance of hypertension to treatment. Identification of drug-related hypertension can be achieved with a thorough medical history targeted to ascertain concurrent therapies that are prescribed for conditions other than cardiovascular diseases. This can avoid prescribing a more aggressive antihypertensive treatment and may prevent embarking in costly and sometimes invasive diagnostic procedures. Drugs that commonly raise blood pressure include NSAIDs, steroids, oestroprogestinic agents, immunosuppressants, erythropoietin, inhibitors of angiogenesis, anti-HIV agents, and also some high-density lipoprotein-raising agents. As withdrawal of the offending drug is often impracticable, knowledge of the mechanism(s) by which each drug exerts its pressor effects may help selecting the most effective treatment. Purpose of this review is to examine the most common causes of resistant hypertension that are due to drugs or abuse of substances along with their underlying pathophysiological mechanisms. The strategy for selecting the most appropriate treatment and the reasons for 'a call of action' of research in this area are also examined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002334     DOI: 10.1097/HJH.0b013e32834c465d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  12 in total

Review 1.  Assessment and management of resistant hypertension.

Authors:  Raj S Padwal; Simon Rabkin; Nadia Khan
Journal:  CMAJ       Date:  2014-08-18       Impact factor: 8.262

Review 2.  Drug-Induced Hypertension: Focus on Mechanisms and Management.

Authors:  Alexandra R Lovell; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

3.  What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question.

Authors:  Tomasz Sobierajski; Stanisław Surma; Monika Romańczyk; Krzysztof Łabuzek; Krzysztof J Filipiak; Suzanne Oparil
Journal:  Int J Environ Res Public Health       Date:  2022-07-05       Impact factor: 4.614

4.  A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.

Authors:  Maniselvan Kuppusamy; Brasilina Caroccia; Julia Stindl; Sascha Bandulik; Livia Lenzini; Francesca Gioco; Veniamin Fishman; Giuseppe Zanotti; Celso Gomez-Sanchez; Michael Bader; Richard Warth; Gian Paolo Rossi
Journal:  J Clin Endocrinol Metab       Date:  2014-07-24       Impact factor: 5.958

Review 5.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

6.  Concentration addition, independent action and generalized concentration addition models for mixture effect prediction of sex hormone synthesis in vitro.

Authors:  Niels Hadrup; Camilla Taxvig; Mikael Pedersen; Christine Nellemann; Ulla Hass; Anne Marie Vinggaard
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

7.  Steroid Anti-Inflammatory Effects Did Not Improve Organ Quality in Brain-Dead Rats.

Authors:  Rolando A Rebolledo; Bo Liu; Mohammed Z Akhtar; Petra J Ottens; Jian-Ning Zhang; Rutger J Ploeg; Henri G D Leuvenink
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

Review 8.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Authors:  Andrea M Isidori; Chiara Graziadio; Rosa Maria Paragliola; Alessia Cozzolino; Alberto G Ambrogio; Annamaria Colao; Salvatore M Corsello; Rosario Pivonello
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

9.  Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock.

Authors:  Kiran K Nandra; Massimo Collino; Mara Rogazzo; Roberto Fantozzi; Nimesh S A Patel; Christoph Thiemermann
Journal:  Dis Model Mech       Date:  2012-12-20       Impact factor: 5.758

Review 10.  Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Authors:  Giuseppe Maiolino; Matteo Azzolini; Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.